Immunology Drugmaker Electra Seeks to Raise $347 Million in IPO
The clinical-stage developer of immunology drugs plans to raise up to $347 million through a US initial public offering.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- Electra Therapeutics Inc.